<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>Molecular Reference</title><description>Plain-English, primary-source-cited peptide &amp; amino-acid reference.</description><link>https://molecularreference.com</link><item><title>BPC-157: does the Wolverine peptide actually heal?</title><link>https://molecularreference.com/peptides/bpc-157</link><guid isPermaLink="true">https://molecularreference.com/peptides/bpc-157</guid><description>BPC-157 shows strong tendon, ligament and gut healing in animals and glowing gym reports, but human proof is only just starting and it&apos;s not FDA-approved.</description><pubDate>Mon, 20 Jul 2026 00:00:00 GMT</pubDate></item><item><title>CJC-1295 peptide: DAC vs no-DAC &amp; ipamorelin</title><link>https://molecularreference.com/peptides/cjc-1295</link><guid isPermaLink="true">https://molecularreference.com/peptides/cjc-1295</guid><description>CJC-1295 (DAC or no-DAC) raises GH and IGF-1 in human trials. The ipamorelin stack, real doses, honest side effects, and 2026 legal status.</description><pubDate>Mon, 20 Jul 2026 00:00:00 GMT</pubDate></item><item><title>GHK-Cu copper peptide: skin, hair, topical vs injected</title><link>https://molecularreference.com/peptides/ghk-cu</link><guid isPermaLink="true">https://molecularreference.com/peptides/ghk-cu</guid><description>GHK-Cu copper peptide has real but mixed human evidence for topical skin, and none for injections or hair. The doses people run, letdowns, 2026 status.</description><pubDate>Mon, 20 Jul 2026 00:00:00 GMT</pubDate></item><item><title>IGF-1 LR3 for muscle growth: does it actually work?</title><link>https://molecularreference.com/peptides/igf-1-lr3</link><guid isPermaLink="true">https://molecularreference.com/peptides/igf-1-lr3</guid><description>IGF-1 LR3 is the long-acting IGF-1 bodybuilders inject for muscle growth — with zero human trials behind it. Real doses, honest risks, 2026 legal status.</description><pubDate>Mon, 20 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Ipamorelin: gentle GH peptide for recovery &amp; gains</title><link>https://molecularreference.com/peptides/ipamorelin</link><guid isPermaLink="true">https://molecularreference.com/peptides/ipamorelin</guid><description>Ipamorelin reliably bumps your own growth hormone; the recovery and lean gains lifters stack it with CJC-1295 for aren&apos;t human-proven yet. What people report.</description><pubDate>Mon, 20 Jul 2026 00:00:00 GMT</pubDate></item><item><title>KPV peptide for gut inflammation: does it work?</title><link>https://molecularreference.com/peptides/kpv</link><guid isPermaLink="true">https://molecularreference.com/peptides/kpv</guid><description>KPV is an anti-inflammatory fragment of alpha-MSH people use for gut inflammation and IBD. Strong mouse data, no human trials, 2026 FDA review pending.</description><pubDate>Mon, 20 Jul 2026 00:00:00 GMT</pubDate></item><item><title>MK-677 (ibutamoren): muscle, sleep &amp; real side effects</title><link>https://molecularreference.com/peptides/mk-677</link><guid isPermaLink="true">https://molecularreference.com/peptides/mk-677</guid><description>MK-677 (ibutamoren) is an oral GH secretagogue people run for sleep, appetite and fuller muscles. The real doses, the water retention and hunger, 2026 status.</description><pubDate>Mon, 20 Jul 2026 00:00:00 GMT</pubDate></item><item><title>MOTS-c peptide for energy: does it actually work?</title><link>https://molecularreference.com/peptides/mots-c</link><guid isPermaLink="true">https://molecularreference.com/peptides/mots-c</guid><description>MOTS-c for energy has strong mouse data but no completed human trial yet. The doses people actually run, honest side effects, and 2026 legal status.</description><pubDate>Mon, 20 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Pentadeca Arginate (PDA): better than BPC-157?</title><link>https://molecularreference.com/peptides/pentadeca-arginate</link><guid isPermaLink="true">https://molecularreference.com/peptides/pentadeca-arginate</guid><description>Pentadeca Arginate (PDA) is BPC-157 as an arginine salt, sold as a sturdier successor. What people report, what&apos;s actually proven, and its 2026 status.</description><pubDate>Mon, 20 Jul 2026 00:00:00 GMT</pubDate></item><item><title>PT-141 for libido &amp; arousal: does it actually work?</title><link>https://molecularreference.com/peptides/pt-141</link><guid isPermaLink="true">https://molecularreference.com/peptides/pt-141</guid><description>PT-141 (bremelanotide) is the FDA-approved libido peptide for women, used off-label by men for arousal. How it feels, real doses, timing, and the nausea.</description><pubDate>Mon, 20 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Retatrutide for weight loss: results, doses, safety</title><link>https://molecularreference.com/peptides/retatrutide</link><guid isPermaLink="true">https://molecularreference.com/peptides/retatrutide</guid><description>Retatrutide is the triple-agonist peptide behind ~28% weight loss in phase 3 — the strongest GLP-1-class results yet. Doses, side effects, 2026 status.</description><pubDate>Mon, 20 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Selank for anxiety and calm focus: nasal vs injected</title><link>https://molecularreference.com/peptides/selank</link><guid isPermaLink="true">https://molecularreference.com/peptides/selank</guid><description>Selank is a Russian anti-anxiety peptide people use for calm, steadier nerves, and clear-headed focus. Nasal vs injected, real doses, and the honest risks.</description><pubDate>Mon, 20 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Semaglutide for weight loss: does it actually work?</title><link>https://molecularreference.com/peptides/semaglutide</link><guid isPermaLink="true">https://molecularreference.com/peptides/semaglutide</guid><description>Semaglutide (Ozempic, Wegovy) drove about 15% body-weight loss in trials — a rare, RCT-backed yes. The doses people run, side effects, regain, 2026 status.</description><pubDate>Mon, 20 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Semax for focus &amp; mood: the Russian nootropic peptide</title><link>https://molecularreference.com/peptides/semax</link><guid isPermaLink="true">https://molecularreference.com/peptides/semax</guid><description>Semax is a Russian nootropic peptide used for focus, mood, and cognition. What people report, nasal vs injected, real doses, and the honest evidence.</description><pubDate>Mon, 20 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Sermorelin peptide: anti-aging, GH, recovery</title><link>https://molecularreference.com/peptides/sermorelin</link><guid isPermaLink="true">https://molecularreference.com/peptides/sermorelin</guid><description>Sermorelin is the GHRH peptide behind the telehealth anti-aging boom. What it does for GH and recovery, the doses people run, and its 2026 legal status.</description><pubDate>Mon, 20 Jul 2026 00:00:00 GMT</pubDate></item><item><title>TB-500 for healing: does it actually work?</title><link>https://molecularreference.com/peptides/tb-500</link><guid isPermaLink="true">https://molecularreference.com/peptides/tb-500</guid><description>TB-500 for healing has real animal data but no finished human trial yet. What people run it for, the BPC-157 stack, side effects, and 2026 legal status.</description><pubDate>Mon, 20 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Tesamorelin peptide for visceral belly fat: does it work?</title><link>https://molecularreference.com/peptides/tesamorelin</link><guid isPermaLink="true">https://molecularreference.com/peptides/tesamorelin</guid><description>Tesamorelin is the GHRH peptide FDA-approved to shrink visceral belly fat. What people report, honest doses, side effects, and 2026 legal status.</description><pubDate>Mon, 20 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Tirzepatide for weight loss: does it beat semaglutide?</title><link>https://molecularreference.com/peptides/tirzepatide</link><guid isPermaLink="true">https://molecularreference.com/peptides/tirzepatide</guid><description>Tirzepatide (Mounjaro/Zepbound) for weight loss: the ~20% loss people report, real titration doses, side effects, and how it compares to semaglutide.</description><pubDate>Mon, 20 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Cagrilintide: the amylin analogue behind CagriSema</title><link>https://molecularreference.com/peptides/cagrilintide</link><guid isPermaLink="true">https://molecularreference.com/peptides/cagrilintide</guid><description>Cagrilintide is a long-acting amylin analogue studied for weight loss, solo and as the amylin half of CagriSema — what it is, the trials, and the risks.</description><pubDate>Fri, 17 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Cartalax peptide: the evidence &amp; the risks</title><link>https://molecularreference.com/peptides/cartalax</link><guid isPermaLink="true">https://molecularreference.com/peptides/cartalax</guid><description>The cartalax peptide is sold for joints, but evidence stops at cell culture. See what the research shows, plus dose, safety, and FDA gaps.</description><pubDate>Fri, 17 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Exenatide: what it is, the evidence &amp; risks</title><link>https://molecularreference.com/peptides/exenatide</link><guid isPermaLink="true">https://molecularreference.com/peptides/exenatide</guid><description>Exenatide is an FDA-approved GLP-1 receptor agonist for type 2 diabetes, derived from Gila monster venom: how it works, what the trials show, and the risks.</description><pubDate>Fri, 17 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Mazdutide: what it is, the evidence &amp; the risks</title><link>https://molecularreference.com/peptides/mazdutide</link><guid isPermaLink="true">https://molecularreference.com/peptides/mazdutide</guid><description>Mazdutide is a GLP-1/glucagon dual-agonist peptide studied in human trials for weight loss and blood sugar — what it is, the evidence, and the risks.</description><pubDate>Fri, 17 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Melitane: tanning peptide evidence &amp; risks</title><link>https://molecularreference.com/peptides/melitane</link><guid isPermaLink="true">https://molecularreference.com/peptides/melitane</guid><description>Melitane (acetyl hexapeptide-1) is a topical MC1R agonist marketed to stimulate melanin and support a gradual tan. See the mechanism and evidence gaps.</description><pubDate>Fri, 17 Jul 2026 00:00:00 GMT</pubDate></item><item><title>NAD peptide guide: NAD+ evidence, forms and risks</title><link>https://molecularreference.com/peptides/nad</link><guid isPermaLink="true">https://molecularreference.com/peptides/nad</guid><description>The nad peptide is actually NAD+, a coenzyme. See what human trials show, how injections differ from precursors, and the 2026 safety reality.</description><pubDate>Fri, 17 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Survodutide: the evidence, weight loss &amp; the risks</title><link>https://molecularreference.com/peptides/survodutide</link><guid isPermaLink="true">https://molecularreference.com/peptides/survodutide</guid><description>Survodutide is an investigational glucagon/GLP-1 dual agonist studied for weight loss and fatty-liver disease — the human trials and the honest risks.</description><pubDate>Fri, 17 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Thymulin peptide: zinc-bound activity &amp; the evidence</title><link>https://molecularreference.com/peptides/thymulin</link><guid isPermaLink="true">https://molecularreference.com/peptides/thymulin</guid><description>The thymulin tfa salt link peptide phrase mixes a TFA counterion with zinc activation. See what each term means and what human evidence exists.</description><pubDate>Fri, 17 Jul 2026 00:00:00 GMT</pubDate></item><item><title>VIP peptide: human trials, nasal spray &amp; risks</title><link>https://molecularreference.com/peptides/vip</link><guid isPermaLink="true">https://molecularreference.com/peptides/vip</guid><description>VIP peptide is a natural 28-amino-acid signal with human lung trials, a short half-life, and no FDA approval. See the evidence, routes, and risks.</description><pubDate>Fri, 17 Jul 2026 00:00:00 GMT</pubDate></item><item><title>ACE-031: what it is, the evidence &amp; why it stopped</title><link>https://molecularreference.com/peptides/ace-031</link><guid isPermaLink="true">https://molecularreference.com/peptides/ace-031</guid><description>ACE-031 is ramatercept, an ActRIIB-Fc muscle-growth drug abandoned after bleeding and blood-vessel side effects. See the human evidence and risks.</description><pubDate>Thu, 16 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Acetyl Tetrapeptide-3: evidence &amp; risks</title><link>https://molecularreference.com/peptides/acetyl-tetrapeptide-3</link><guid isPermaLink="true">https://molecularreference.com/peptides/acetyl-tetrapeptide-3</guid><description>Acetyl Tetrapeptide-3 is a cosmetic hair peptide with in-vitro evidence, but Capixyl trials test blends. See the real evidence and topical risks.</description><pubDate>Thu, 16 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Does Acetyl Tetrapeptide-5 (Eyeseryl) work?</title><link>https://molecularreference.com/peptides/acetyl-tetrapeptide-5</link><guid isPermaLink="true">https://molecularreference.com/peptides/acetyl-tetrapeptide-5</guid><description>Does acetyl tetrapeptide-5 reduce eye bags? The mechanism is plausible, but supplier data outruns the independent human evidence.</description><pubDate>Thu, 16 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Adipotide: what it is, the evidence &amp; the risks</title><link>https://molecularreference.com/peptides/adipotide</link><guid isPermaLink="true">https://molecularreference.com/peptides/adipotide</guid><description>Adipotide caused fat loss in obese monkeys, but kidney injury followed and human results remain unpublished. See the evidence andundefinedstatus.</description><pubDate>Thu, 16 Jul 2026 00:00:00 GMT</pubDate></item><item><title>AICAR: what it is, the evidence &amp; the risks</title><link>https://molecularreference.com/peptides/aicar</link><guid isPermaLink="true">https://molecularreference.com/peptides/aicar</guid><description>AICAR is a nucleoside AMPK activator, not a peptide. See the mouse endurance result, failed human cardiac trial, safety gaps, and 2026 status.</description><pubDate>Thu, 16 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Amycretin: what it is, the evidence &amp; the risks</title><link>https://molecularreference.com/peptides/amycretin</link><guid isPermaLink="true">https://molecularreference.com/peptides/amycretin</guid><description>Amycretin is Novo Nordisk&apos;s investigational GLP-1/amylin peptide. See the human weight-loss results, oral option, GI risks, andundefinedFDA status.</description><pubDate>Thu, 16 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Anamorelin: what it is, the evidence &amp; the risks</title><link>https://molecularreference.com/peptides/anamorelin</link><guid isPermaLink="true">https://molecularreference.com/peptides/anamorelin</guid><description>Anamorelin is an oral ghrelin agonist that added lean mass without improving strength in major cancer-cachexia trials. See the evidence, status, and risks.</description><pubDate>Thu, 16 Jul 2026 00:00:00 GMT</pubDate></item><item><title>B7-33: what it is, the evidence &amp; the risks</title><link>https://molecularreference.com/peptides/b7-33</link><guid isPermaLink="true">https://molecularreference.com/peptides/b7-33</guid><description>B7-33 is a biased RXFP1 agonist with anti-fibrotic results in cells and rodents, but no human trials, approved dose, or established safety profile.</description><pubDate>Thu, 16 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Bimagrumab: what it is, the evidence &amp; the risks</title><link>https://molecularreference.com/peptides/bimagrumab</link><guid isPermaLink="true">https://molecularreference.com/peptides/bimagrumab</guid><description>Bimagrumab is an investigational antibody that reduces fat while limiting lean-mass loss. See the human evidence, side effects, andundefinedstatus.</description><pubDate>Thu, 16 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Biotinoyl Tripeptide-1: evidence &amp; risks</title><link>https://molecularreference.com/peptides/biotinoyl-tripeptide-1</link><guid isPermaLink="true">https://molecularreference.com/peptides/biotinoyl-tripeptide-1</guid><description>Biotinoyl Tripeptide-1 is a cosmetic hair peptide with cultured-follicle data but no isolated human trial. See the evidence, Procapil caveat, and risks.</description><pubDate>Thu, 16 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Colostrinin: what it is, the evidence &amp; risks</title><link>https://molecularreference.com/peptides/colostrinin</link><guid isPermaLink="true">https://molecularreference.com/peptides/colostrinin</guid><description>Colostrinin is a colostrum peptide mixture with small human cognition trials. See the Alzheimer&apos;s evidence, supplement status, doses, and risks.</description><pubDate>Thu, 16 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Cortagen: what it is, the evidence &amp; the risks</title><link>https://molecularreference.com/peptides/cortagen</link><guid isPermaLink="true">https://molecularreference.com/peptides/cortagen</guid><description>Cortagen is an AEDP tetrapeptide with animal nerve-regeneration data, no controlled human trial, and no FDA approval. See the evidence and risks.</description><pubDate>Thu, 16 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Cortexin: what it is, the evidence &amp; the risks</title><link>https://molecularreference.com/peptides/cortexin</link><guid isPermaLink="true">https://molecularreference.com/peptides/cortexin</guid><description>A cortexin review of the cattle-brain peptide extract, weak nootropic evidence, injection risks, prion question, and 2026 FDA status.</description><pubDate>Thu, 16 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Danuglipron: the evidence &amp; why Pfizer killed it</title><link>https://molecularreference.com/peptides/danuglipron</link><guid isPermaLink="true">https://molecularreference.com/peptides/danuglipron</guid><description>Danuglipron was Pfizer&apos;s oral GLP-1 pill: effective in human trials, but discontinued after one potential liver-injury case.</description><pubDate>Thu, 16 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Davunetide: what it is, the evidence &amp; the risks</title><link>https://molecularreference.com/peptides/davunetide</link><guid isPermaLink="true">https://molecularreference.com/peptides/davunetide</guid><description>Davunetide is a nootropic peptide with a real phase 2/3 human trial—and no benefit for PSP. See the evidence, safety findings, and 2026 status.</description><pubDate>Thu, 16 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Decapeptide-12: what it is, evidence &amp; risks</title><link>https://molecularreference.com/peptides/decapeptide-12</link><guid isPermaLink="true">https://molecularreference.com/peptides/decapeptide-12</guid><description>Decapeptide-12 is a topical tyrosinase inhibitor studied for melasma and dark spots. See what the small human studies show and what remains unknown.</description><pubDate>Thu, 16 Jul 2026 00:00:00 GMT</pubDate></item><item><title>DSIP: what it is, the evidence &amp; the risks</title><link>https://molecularreference.com/peptides/dsip</link><guid isPermaLink="true">https://molecularreference.com/peptides/dsip</guid><description>DSIP is a nine-amino-acid sleep peptide with small, conflicting human trials and no FDA approval. See the old evidence, current risks, and honest verdict.</description><pubDate>Thu, 16 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Ecnoglutide: what it is, the evidence &amp; the risks</title><link>https://molecularreference.com/peptides/ecnoglutide</link><guid isPermaLink="true">https://molecularreference.com/peptides/ecnoglutide</guid><description>Ecnoglutide is a cAMP-biased GLP-1 drug with Phase 3 weight-loss data, China approval, no U.S. approval, and real gastrointestinal risks.</description><pubDate>Thu, 16 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Epidermal growth factor (EGF) (EGF): evidence &amp; risks</title><link>https://molecularreference.com/peptides/epidermal-growth-factor</link><guid isPermaLink="true">https://molecularreference.com/peptides/epidermal-growth-factor</guid><description>Epidermal growth factor (EGF) (EGF) has real wound data, but thin anti-wrinkle evidence. See what EGF serum can plausibly do, penetration limits, and risks.</description><pubDate>Thu, 16 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Gonadorelin: what it is, the evidence &amp; the risks</title><link>https://molecularreference.com/peptides/gonadorelin</link><guid isPermaLink="true">https://molecularreference.com/peptides/gonadorelin</guid><description>Gonadorelin can restore reproductive hormones when delivered in frequent pulses, but TRT-clinic injections do not match the studied pump regimen.</description><pubDate>Thu, 16 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Hexapeptide-11: Evidence, Uses &amp; Honest Risks</title><link>https://molecularreference.com/peptides/hexapeptide-11</link><guid isPermaLink="true">https://molecularreference.com/peptides/hexapeptide-11</guid><description>Hexapeptide-11 is a yeast-derived skincare peptide with lab evidence for fibroblast senescence, but no established wrinkle benefit. See uses and risks.</description><pubDate>Thu, 16 Jul 2026 00:00:00 GMT</pubDate></item><item><title>IGF-1 DES: what it is, the evidence &amp; the risks</title><link>https://molecularreference.com/peptides/igf-1-des</link><guid isPermaLink="true">https://molecularreference.com/peptides/igf-1-des</guid><description>IGF-1 DES is a 67-amino-acid IGF-1 fragment with animal and cell evidence, no human trials, no FDA approval, and no proven spot-growth effect.</description><pubDate>Thu, 16 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Kisspeptin-10: what it is, evidence &amp; risks</title><link>https://molecularreference.com/peptides/kisspeptin-10</link><guid isPermaLink="true">https://molecularreference.com/peptides/kisspeptin-10</guid><description>Kisspeptin-10 raises reproductive hormones in small human studies, but libido claims often borrow data from a longer peptide. See the evidence and risks.</description><pubDate>Thu, 16 Jul 2026 00:00:00 GMT</pubDate></item><item><title>The Klotho protein: evidence, trials &amp; risks</title><link>https://molecularreference.com/peptides/klotho</link><guid isPermaLink="true">https://molecularreference.com/peptides/klotho</guid><description>Klotho is a large human protein, not an injectable peptide. See the observational evidence, offshore gene-therapy trials, supplement claims, and risks.</description><pubDate>Thu, 16 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Lactoferrin: what it is, the evidence &amp; the risks</title><link>https://molecularreference.com/peptides/lactoferrin</link><guid isPermaLink="true">https://molecularreference.com/peptides/lactoferrin</guid><description>Lactoferrin is an iron-binding milk protein with decent anemia evidence but weaker immune claims. See the benefits, risks, and supplement status.</description><pubDate>Thu, 16 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Livagen: what it is, the evidence &amp; the risks</title><link>https://molecularreference.com/peptides/livagen</link><guid isPermaLink="true">https://molecularreference.com/peptides/livagen</guid><description>The livagen peptide is KEDA, a synthetic bioregulator studied in cultured cells—not a proven liver treatment. See the evidence, risks, and 2026 status.</description><pubDate>Thu, 16 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Macimorelin: what it is, the evidence &amp; the risks</title><link>https://molecularreference.com/peptides/macimorelin</link><guid isPermaLink="true">https://molecularreference.com/peptides/macimorelin</guid><description>Macimorelin is an FDA-approved oral test for adult growth hormone deficiency, not a GH treatment. See the evidence, procedure, limits, and risks.</description><pubDate>Thu, 16 Jul 2026 00:00:00 GMT</pubDate></item><item><title>MariTide (maridebart cafraglutide): evidence &amp; risks</title><link>https://molecularreference.com/peptides/maritide</link><guid isPermaLink="true">https://molecularreference.com/peptides/maritide</guid><description>MariTide is Amgen&apos;s monthly obesity candidate: human weight-loss evidence, the GIP-antagonist paradox, side effects, and 2026 FDA status.</description><pubDate>Thu, 16 Jul 2026 00:00:00 GMT</pubDate></item><item><title>MGF peptide: evidence, results &amp; risks</title><link>https://molecularreference.com/peptides/mgf</link><guid isPermaLink="true">https://molecularreference.com/peptides/mgf</guid><description>MGF peptide is a 24-amino-acid IGF-1Ec fragment with conflicting cell evidence, no human treatment trials, and major safety unknowns.</description><pubDate>Thu, 16 Jul 2026 00:00:00 GMT</pubDate></item><item><title>N-Acetyl Semax Amidate: evidence &amp; risks</title><link>https://molecularreference.com/peptides/n-acetyl-semax-amidate</link><guid isPermaLink="true">https://molecularreference.com/peptides/n-acetyl-semax-amidate</guid><description>N-Acetyl Semax Amidate is a dual-modified Semax analog with no direct human trials. See what the chemistry supports, what remains untested, and the risks.</description><pubDate>Thu, 16 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Nonapeptide-1: what it is, evidence &amp; risks</title><link>https://molecularreference.com/peptides/nonapeptide-1</link><guid isPermaLink="true">https://molecularreference.com/peptides/nonapeptide-1</guid><description>Nonapeptide-1 is a topical MC1R antagonist peptide sold for skin brightening. See what cell studies, combination trials, and safety data show.</description><pubDate>Thu, 16 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Oxytocin: what it is, the evidence &amp; the risks</title><link>https://molecularreference.com/peptides/oxytocin</link><guid isPermaLink="true">https://molecularreference.com/peptides/oxytocin</guid><description>Oxytocin is an approved obstetric drug, but nasal-spray claims about bonding, autism and anxiety have mixed human evidence.</description><pubDate>Thu, 16 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Palmitoyl Tetrapeptide-7: evidence &amp; risks</title><link>https://molecularreference.com/peptides/palmitoyl-tetrapeptide-7</link><guid isPermaLink="true">https://molecularreference.com/peptides/palmitoyl-tetrapeptide-7</guid><description>Palmitoyl Tetrapeptide-7 is a cosmetic peptide with in-vitro IL-6 evidence. See what the cell data show, what remains unproven, and topical risks.</description><pubDate>Thu, 16 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Palmitoyl Tripeptide-38: the evidence &amp; risks</title><link>https://molecularreference.com/peptides/palmitoyl-tripeptide-38</link><guid isPermaLink="true">https://molecularreference.com/peptides/palmitoyl-tripeptide-38</guid><description>Palmitoyl tripeptide-38 is the Synthe&apos;6 peptide sold for wrinkles, but isolated human proof is missing. See the benefits, limits, and risks.</description><pubDate>Thu, 16 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Pancragen: what it is, the evidence &amp; the risks</title><link>https://molecularreference.com/peptides/pancragen</link><guid isPermaLink="true">https://molecularreference.com/peptides/pancragen</guid><description>Pancragen is a KEDW pancreas bioregulator with thin human evidence, animal glucose findings, no FDA approval, and no established human dosage.</description><pubDate>Thu, 16 Jul 2026 00:00:00 GMT</pubDate></item><item><title>PE-22-28: what it is, the evidence &amp; the risks</title><link>https://molecularreference.com/peptides/pe-22-28</link><guid isPermaLink="true">https://molecularreference.com/peptides/pe-22-28</guid><description>PE-22-28 is a synthetic TREK-1 blocker studied only in cells and mice. See the depression evidence, unknown human dosage, safety gaps, and 2026 status.</description><pubDate>Thu, 16 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Pemvidutide: what it is, the evidence &amp; the risks</title><link>https://molecularreference.com/peptides/pemvidutide</link><guid isPermaLink="true">https://molecularreference.com/peptides/pemvidutide</guid><description>Pemvidutide is an investigational GLP-1/glucagon peptide with human MASH and weight-loss data. See what hit, what missed, and the risks.</description><pubDate>Thu, 16 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Pentapeptide-18 (Leuphasyl): evidence &amp; risks</title><link>https://molecularreference.com/peptides/pentapeptide-18</link><guid isPermaLink="true">https://molecularreference.com/peptides/pentapeptide-18</guid><description>Pentapeptide-18 (Leuphasyl) is an enkephalin-like cosmetic peptide with supplier-led wrinkle data. See the evidence, opioid angle, and risks.</description><pubDate>Thu, 16 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Petrelintide: what it is, the evidence &amp; the risks</title><link>https://molecularreference.com/peptides/petrelintide</link><guid isPermaLink="true">https://molecularreference.com/peptides/petrelintide</guid><description>Petrelintide is an investigational weekly amylin analog with Phase 2 weight-loss results. See what ZUPREME-1 found, plus risks and 2026 status.</description><pubDate>Thu, 16 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Pidotimod: what it is, the evidence &amp; the risks</title><link>https://molecularreference.com/peptides/pidotimod</link><guid isPermaLink="true">https://molecularreference.com/peptides/pidotimod</guid><description>Pidotimod is a non-peptide immunostimulant with pediatric human trials, Italian approval, mixed evidence, and no FDA-approved U.S. product.</description><pubDate>Thu, 16 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Pinealon: what it is, the evidence &amp; the risks</title><link>https://molecularreference.com/peptides/pinealon</link><guid isPermaLink="true">https://molecularreference.com/peptides/pinealon</guid><description>Pinealon is an EDR tripeptide with cell and animal research, no validated human benefit, and major safety unknowns. See the evidence and risks.</description><pubDate>Thu, 16 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Pramlintide: what it is, the evidence &amp; the risks</title><link>https://molecularreference.com/peptides/pramlintide</link><guid isPermaLink="true">https://molecularreference.com/peptides/pramlintide</guid><description>Pramlintide is the original FDA-approved amylin analog: modest weight loss, mealtime dosing, a boxed warning, and Symlin&apos;s discontinued status.</description><pubDate>Thu, 16 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Rapastinel: what it is, the evidence &amp; the risks</title><link>https://molecularreference.com/peptides/rapastinel</link><guid isPermaLink="true">https://molecularreference.com/peptides/rapastinel</guid><description>Rapastinel (GLYX-13) reached Phase 3 for depression but failed against placebo. See how it works, why it failed, and the safety and legal facts.</description><pubDate>Thu, 16 Jul 2026 00:00:00 GMT</pubDate></item><item><title>SLU-PP-332: what it is, the evidence &amp; the risks</title><link>https://molecularreference.com/peptides/slu-pp-332</link><guid isPermaLink="true">https://molecularreference.com/peptides/slu-pp-332</guid><description>SLU-PP-332 is a small-molecule exercise mimetic tested in mice, not a peptide or human-ready drug. See the evidence, unknowns, and 2026 status.</description><pubDate>Thu, 16 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Somatropin (HGH): evidence, risks &amp; federal law</title><link>https://molecularreference.com/peptides/somatropin</link><guid isPermaLink="true">https://molecularreference.com/peptides/somatropin</guid><description>Somatropin is FDA-approved recombinant human growth hormone. See the evidence, injection risks, anti-aging limits, sports ban, and unusual federal law.</description><pubDate>Thu, 16 Jul 2026 00:00:00 GMT</pubDate></item><item><title>SS-20: The Other Szeto-Schiller Mito Peptide</title><link>https://molecularreference.com/peptides/ss-20</link><guid isPermaLink="true">https://molecularreference.com/peptides/ss-20</guid><description>SS-20 is a mitochondrial peptide with animal-only evidence, no approved human use, and a mechanism that changed how researchers read SS-31 (elamipretide).</description><pubDate>Thu, 16 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Teduglutide: what it is, the evidence &amp; the risks</title><link>https://molecularreference.com/peptides/teduglutide</link><guid isPermaLink="true">https://molecularreference.com/peptides/teduglutide</guid><description>Teduglutide is the FDA-approved GLP-2 drug for short bowel syndrome; see the human evidence, mucosal growth, side effects, and required surveillance.</description><pubDate>Thu, 16 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Teriparatide: what it is, the evidence &amp; the risks</title><link>https://molecularreference.com/peptides/teriparatide</link><guid isPermaLink="true">https://molecularreference.com/peptides/teriparatide</guid><description>FDA-approved teriparatide treats high-risk osteoporosis, but evidence for fracture healing is mixed. See what Forteo does, its dosage, and risks.</description><pubDate>Thu, 16 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Thymogen (Glu-Trp): evidence &amp; risks</title><link>https://molecularreference.com/peptides/thymogen</link><guid isPermaLink="true">https://molecularreference.com/peptides/thymogen</guid><description>Thymogen is the Glu-Trp dipeptide isolated from Thymalin. See the animal-only aging evidence, limited human immune data, U.S. status, and risks.</description><pubDate>Thu, 16 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Thymopentin (TP-5): evidence &amp; risks</title><link>https://molecularreference.com/peptides/thymopentin</link><guid isPermaLink="true">https://molecularreference.com/peptides/thymopentin</guid><description>Thymopentin is a five-amino-acid immune peptide with mixed human trial results. See what TP-5 showed, where it failed, dosing, safety, and FDA status.</description><pubDate>Thu, 16 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Trofinetide (Daybue): Evidence, Dosing &amp; Risks</title><link>https://molecularreference.com/peptides/trofinetide</link><guid isPermaLink="true">https://molecularreference.com/peptides/trofinetide</guid><description>A clear guide to trofinetide (Daybue): LAVENDER evidence, Rett syndrome dosing, side effects, FDA status, and what the IGF-1 link really means.</description><pubDate>Thu, 16 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Vesugen: what it is, the evidence &amp; the risks</title><link>https://molecularreference.com/peptides/vesugen</link><guid isPermaLink="true">https://molecularreference.com/peptides/vesugen</guid><description>The vesugen peptide is KED (Lys-Glu-Asp), a vascular bioregulator with cell studies, weak human reports, no FDA approval, and major safety gaps.</description><pubDate>Thu, 16 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Vilon: what it is, the evidence &amp; the risks</title><link>https://molecularreference.com/peptides/vilon</link><guid isPermaLink="true">https://molecularreference.com/peptides/vilon</guid><description>Vilon is the Lys-Glu bioregulator studied mainly in cells and animals, with limited Russian clinical reports. See the evidence, risks, andundefinedstatus.</description><pubDate>Thu, 16 Jul 2026 00:00:00 GMT</pubDate></item><item><title>VK2735: what it is, the evidence &amp; the risks</title><link>https://molecularreference.com/peptides/vk2735</link><guid isPermaLink="true">https://molecularreference.com/peptides/vk2735</guid><description>VK2735 is an investigational GIP/GLP-1 peptide with Phase 2 weight-loss results. See the doses, risks, oral data, and 2026 status.</description><pubDate>Thu, 16 Jul 2026 00:00:00 GMT</pubDate></item><item><title>AOD-9604: the fat-loss GH fragment, evidence &amp; risks</title><link>https://molecularreference.com/peptides/aod-9604</link><guid isPermaLink="true">https://molecularreference.com/peptides/aod-9604</guid><description>AOD-9604 is a growth-hormone fragment studied for fat loss — what it is, the honest evidence, the risks, and its dated 2026 legal status.</description><pubDate>Wed, 15 Jul 2026 00:00:00 GMT</pubDate></item><item><title>ARA-290: what it is, the evidence &amp; the risks</title><link>https://molecularreference.com/peptides/ara-290</link><guid isPermaLink="true">https://molecularreference.com/peptides/ara-290</guid><description>ARA-290 (cibinetide) is an EPO-derived peptide studied in small human trials for neuropathic pain and nerve repair — what it is, the evidence, the risks.</description><pubDate>Wed, 15 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Argireline (acetyl hexapeptide-8): does it work?</title><link>https://molecularreference.com/peptides/argireline</link><guid isPermaLink="true">https://molecularreference.com/peptides/argireline</guid><description>Argireline (acetyl hexapeptide-8) is a topical anti-wrinkle peptide with actual human trials — what it is, how it works, and how well it really works.</description><pubDate>Wed, 15 Jul 2026 00:00:00 GMT</pubDate></item><item><title>CagriSema: what it is, the evidence &amp; the risks</title><link>https://molecularreference.com/peptides/cagrisema</link><guid isPermaLink="true">https://molecularreference.com/peptides/cagrisema</guid><description>CagriSema is Novo Nordisk&apos;s investigational cagrilintide plus semaglutide combo for weight loss and type 2 diabetes — the human evidence and honest risks.</description><pubDate>Wed, 15 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Cerebrolysin: what it is, evidence &amp; risks</title><link>https://molecularreference.com/peptides/cerebrolysin</link><guid isPermaLink="true">https://molecularreference.com/peptides/cerebrolysin</guid><description>Cerebrolysin is a pig-brain peptide mixture studied in dozens of human trials for stroke, dementia and brain-injury recovery — the evidence and honest risks.</description><pubDate>Wed, 15 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Defensins: what they are, the evidence &amp; the risks</title><link>https://molecularreference.com/peptides/defensins</link><guid isPermaLink="true">https://molecularreference.com/peptides/defensins</guid><description>Defensins are the body&apos;s own antimicrobial peptides — a front-line arm of innate immunity. What they are, what human research shows, and the honest risks.</description><pubDate>Wed, 15 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Dihexa: what it is, the evidence &amp; the risks</title><link>https://molecularreference.com/peptides/dihexa</link><guid isPermaLink="true">https://molecularreference.com/peptides/dihexa</guid><description>Dihexa is an oral angiotensin IV analog studied in rats and mice for memory and Alzheimer&apos;s — what it is, how it works, and the honest human-data gap.</description><pubDate>Wed, 15 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Dulaglutide (Trulicity): evidence, doses &amp; risks</title><link>https://molecularreference.com/peptides/dulaglutide</link><guid isPermaLink="true">https://molecularreference.com/peptides/dulaglutide</guid><description>Dulaglutide (Trulicity) is an FDA-approved, once-weekly GLP-1 injection for type 2 diabetes — how it works, what the human trials show, and the honest risks.</description><pubDate>Wed, 15 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Epitalon: what it is, the evidence &amp; the risks</title><link>https://molecularreference.com/peptides/epitalon</link><guid isPermaLink="true">https://molecularreference.com/peptides/epitalon</guid><description>Epitalon is a synthetic pineal tetrapeptide studied mostly in cells and mice for telomeres and aging — what it is, the evidence, and the honest risks.</description><pubDate>Wed, 15 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Follistatin: what it is, the evidence &amp; the risks</title><link>https://molecularreference.com/peptides/follistatin</link><guid isPermaLink="true">https://molecularreference.com/peptides/follistatin</guid><description>Follistatin is a myostatin-blocking protein studied in animals and early gene-therapy trials for muscle growth — the evidence and honest risks, explained.</description><pubDate>Wed, 15 Jul 2026 00:00:00 GMT</pubDate></item><item><title>FOXO4-DRI: the senolytic peptide, evidence &amp; risks</title><link>https://molecularreference.com/peptides/foxo4-dri</link><guid isPermaLink="true">https://molecularreference.com/peptides/foxo4-dri</guid><description>FOXO4-DRI is a senolytic peptide studied in mice and human cells to clear senescent &apos;zombie&apos; cells — what it is, the real evidence, and the honest risks.</description><pubDate>Wed, 15 Jul 2026 00:00:00 GMT</pubDate></item><item><title>GDF-11: what it is, the evidence &amp; the risks</title><link>https://molecularreference.com/peptides/gdf-11</link><guid isPermaLink="true">https://molecularreference.com/peptides/gdf-11</guid><description>GDF-11 is the &apos;young blood&apos; protein studied in mice for reversing aging — what it is, why the results are hotly contested, and the honest human risks.</description><pubDate>Wed, 15 Jul 2026 00:00:00 GMT</pubDate></item><item><title>GHRP-2: what it is, the evidence &amp; the risks</title><link>https://molecularreference.com/peptides/ghrp-2</link><guid isPermaLink="true">https://molecularreference.com/peptides/ghrp-2</guid><description>GHRP-2 (pralmorelin) is a growth-hormone secretagogue that reliably raises GH and appetite in humans — what it does, what&apos;s proven, and the honest risks.</description><pubDate>Wed, 15 Jul 2026 00:00:00 GMT</pubDate></item><item><title>GHRP-6: what it is, the evidence &amp; the risks</title><link>https://molecularreference.com/peptides/ghrp-6</link><guid isPermaLink="true">https://molecularreference.com/peptides/ghrp-6</guid><description>GHRP-6 is a growth-hormone secretagogue that reliably triggers a GH pulse and strong hunger in humans — what it is, the evidence, and the honest risks.</description><pubDate>Wed, 15 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Hexarelin: what it does, the evidence &amp; the risks</title><link>https://molecularreference.com/peptides/hexarelin</link><guid isPermaLink="true">https://molecularreference.com/peptides/hexarelin</guid><description>Hexarelin is a synthetic GHRP that reliably raises growth hormone in human studies — what it is, what the evidence really shows, and the honest risks.</description><pubDate>Wed, 15 Jul 2026 00:00:00 GMT</pubDate></item><item><title>HGH Fragment 176-191: fat-loss peptide, evidence &amp; risks</title><link>https://molecularreference.com/peptides/hgh-fragment-176-191</link><guid isPermaLink="true">https://molecularreference.com/peptides/hgh-fragment-176-191</guid><description>HGH fragment 176-191 is the fat-burning tail of growth hormone — what it is, why the evidence is animal-only, the risks, and its 2026 legal status.</description><pubDate>Wed, 15 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Humanin: what it is, the evidence &amp; the risks</title><link>https://molecularreference.com/peptides/humanin</link><guid isPermaLink="true">https://molecularreference.com/peptides/humanin</guid><description>Humanin is a 24-amino-acid mitochondrial-derived peptide studied in cells and animals for brain and metabolic protection — the evidence and the honest risks.</description><pubDate>Wed, 15 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Larazotide: the gut-barrier peptide, evidence &amp; risks</title><link>https://molecularreference.com/peptides/larazotide</link><guid isPermaLink="true">https://molecularreference.com/peptides/larazotide</guid><description>Larazotide is an oral peptide studied in celiac disease to tighten the &apos;leaky&apos; gut barrier — what it is, what the human trials showed, and the honest risks.</description><pubDate>Wed, 15 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Liraglutide: what it is, the evidence &amp; the risks</title><link>https://molecularreference.com/peptides/liraglutide</link><guid isPermaLink="true">https://molecularreference.com/peptides/liraglutide</guid><description>Liraglutide (Victoza, Saxenda) is an FDA-approved GLP-1 peptide for type 2 diabetes and weight loss — what it is, what the trials show, and the honest risks.</description><pubDate>Wed, 15 Jul 2026 00:00:00 GMT</pubDate></item><item><title>LL-37: what it is, the evidence &amp; the risks</title><link>https://molecularreference.com/peptides/ll-37</link><guid isPermaLink="true">https://molecularreference.com/peptides/ll-37</guid><description>LL-37 is the body&apos;s own antimicrobial peptide — sold as a research chemical for infections, biofilms and wounds. What it is, the evidence, the honest risks.</description><pubDate>Wed, 15 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Matrixyl: what it is, the evidence &amp; the risks</title><link>https://molecularreference.com/peptides/matrixyl</link><guid isPermaLink="true">https://molecularreference.com/peptides/matrixyl</guid><description>Matrixyl (palmitoyl pentapeptide-4) is a topical peptide studied for fine lines and wrinkles — what it is, what the human research shows, and the honest risks.</description><pubDate>Wed, 15 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Melanotan I (afamelanotide): evidence, tanning &amp; risks</title><link>https://molecularreference.com/peptides/melanotan-i</link><guid isPermaLink="true">https://molecularreference.com/peptides/melanotan-i</guid><description>Melanotan I (afamelanotide, SCENESSE) is an FDA-approved α-MSH analog that raises protective skin pigment — the evidence, the tanning question, and the risks.</description><pubDate>Wed, 15 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Melanotan II: the tanning peptide — evidence &amp; risks</title><link>https://molecularreference.com/peptides/melanotan-ii</link><guid isPermaLink="true">https://molecularreference.com/peptides/melanotan-ii</guid><description>Melanotan II is a synthetic melanocortin peptide studied in humans for skin tanning — what it is, what the evidence shows, and the honest mole and safety risks.</description><pubDate>Wed, 15 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Modified GRF 1-29: what it is, the evidence, risks</title><link>https://molecularreference.com/peptides/mod-grf-1-29</link><guid isPermaLink="true">https://molecularreference.com/peptides/mod-grf-1-29</guid><description>Modified GRF 1-29 (CJC-1295 without DAC) is a GHRH analog used to raise your own growth hormone. What it is, what the research shows, and the honest risks.</description><pubDate>Wed, 15 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Noopept: what it is, the evidence &amp; the risks</title><link>https://molecularreference.com/peptides/noopept</link><guid isPermaLink="true">https://molecularreference.com/peptides/noopept</guid><description>Noopept (omberacetam) is a synthetic nootropic — a dipeptide derivative, not a true peptide — studied for cognition: what it is, the evidence, the risks.</description><pubDate>Wed, 15 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Orforglipron: oral GLP-1 pill — evidence &amp; risks</title><link>https://molecularreference.com/peptides/orforglipron</link><guid isPermaLink="true">https://molecularreference.com/peptides/orforglipron</guid><description>Orforglipron (Foundayo) is a once-daily oral GLP-1 pill, FDA-approved for chronic weight management. What it is, the evidence, and risks.</description><pubDate>Wed, 15 Jul 2026 00:00:00 GMT</pubDate></item><item><title>P021: what it is, the evidence &amp; the risks</title><link>https://molecularreference.com/peptides/p21</link><guid isPermaLink="true">https://molecularreference.com/peptides/p21</guid><description>P021 is a synthetic neurotrophic peptide studied only in animals for memory and brain aging — what it is, what the rodent research shows, and the risks.</description><pubDate>Wed, 15 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Palmitoyl Tripeptide-1: what it is &amp; the evidence</title><link>https://molecularreference.com/peptides/palmitoyl-tripeptide-1</link><guid isPermaLink="true">https://molecularreference.com/peptides/palmitoyl-tripeptide-1</guid><description>Palmitoyl tripeptide-1 is a cosmetic collagen peptide — what it is, what the lab and human evidence really show for wrinkles, and whether it&apos;s worth it.</description><pubDate>Wed, 15 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Setmelanotide (IMCIVREE): evidence, risks &amp; status</title><link>https://molecularreference.com/peptides/setmelanotide</link><guid isPermaLink="true">https://molecularreference.com/peptides/setmelanotide</guid><description>Setmelanotide (IMCIVREE) is an FDA-approved MC4R agonist for rare genetic obesity — the human-trial evidence, how it works, dosing and the honest risks.</description><pubDate>Wed, 15 Jul 2026 00:00:00 GMT</pubDate></item><item><title>SNAP-8 (acetyl octapeptide-3): evidence &amp; honest take</title><link>https://molecularreference.com/peptides/snap-8</link><guid isPermaLink="true">https://molecularreference.com/peptides/snap-8</guid><description>SNAP-8 (acetyl octapeptide-3) is a topical cosmetic peptide sold to soften expression lines — what it is, how it&apos;s claimed to work, and the evidence.</description><pubDate>Wed, 15 Jul 2026 00:00:00 GMT</pubDate></item><item><title>SS-31 (elamipretide): what it is, evidence &amp; risks</title><link>https://molecularreference.com/peptides/ss-31</link><guid isPermaLink="true">https://molecularreference.com/peptides/ss-31</guid><description>SS-31 (elamipretide) is a mitochondria-targeting peptide, now FDA-approved as Forzinity for a rare disease — what it is, the aging evidence, and honest risks.</description><pubDate>Wed, 15 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Syn-Ake: what it is, how it works &amp; the evidence</title><link>https://molecularreference.com/peptides/syn-ake</link><guid isPermaLink="true">https://molecularreference.com/peptides/syn-ake</guid><description>Syn-Ake is a synthetic anti-wrinkle peptide modeled on snake-venom waglerin-1 — what it is, how the topical-Botox idea works, and what the evidence shows.</description><pubDate>Wed, 15 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Tesofensine: what it is, the evidence &amp; the risks</title><link>https://molecularreference.com/peptides/tesofensine</link><guid isPermaLink="true">https://molecularreference.com/peptides/tesofensine</guid><description>Tesofensine is a non-peptide triple reuptake inhibitor studied for weight loss — what it is, what the human trials showed, and the honest risks.</description><pubDate>Wed, 15 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Thymalin: what it is, the evidence &amp; the risks</title><link>https://molecularreference.com/peptides/thymalin</link><guid isPermaLink="true">https://molecularreference.com/peptides/thymalin</guid><description>Thymalin is a thymus-derived peptide studied in Russia for immune restoration and healthy aging — what it is, what the human evidence shows, and the risks.</description><pubDate>Wed, 15 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Thymosin Alpha-1 (Zadaxin): uses, evidence &amp; risks</title><link>https://molecularreference.com/peptides/thymosin-alpha-1</link><guid isPermaLink="true">https://molecularreference.com/peptides/thymosin-alpha-1</guid><description>Thymosin alpha-1 (thymalfasin/Zadaxin) is a thymic immune peptide with real human trials — what it is, how it tunes immunity, and the honest risks.</description><pubDate>Wed, 15 Jul 2026 00:00:00 GMT</pubDate></item><item><title>Thymosin Beta-4: evidence, healing uses &amp; risks</title><link>https://molecularreference.com/peptides/thymosin-beta-4</link><guid isPermaLink="true">https://molecularreference.com/peptides/thymosin-beta-4</guid><description>Thymosin beta-4 is a 43-amino-acid healing peptide with real human trials for dry eye and heart repair, but only animal data for the muscle use it&apos;s sold for.</description><pubDate>Wed, 15 Jul 2026 00:00:00 GMT</pubDate></item></channel></rss>